Design, synthesis and biological evaluation of isoxazole bearing 1, 3-oxazole-1, 3, 4-oxadiazole derivatives as anticancer agents

被引：2
|
作者：
Lingala, Arun Kumar [1 ,2 ]
Murahari, Kiran Kumar [1 ]
Desireddi, Janardana Reddi [1 ,2 ]
Mothe, Thirupathi [1 ,2 ]
Maiti, Bhimcharan [1 ]
Manchal, Ravinder [2 ]
机构：
[1] Aragen Life Sci Pvt Ltd, Previously known GVK Biosci Pvt Ltd, Med Chem Div, 28A,IDA Nacharam, Hyderabad 500076, India
[2] Chaitanya, Dept Chem, Warangal 506001, India
来源：
CHEMICAL DATA COLLECTIONS | 2023年 / 43卷
关键词：
Zibotentan; Luminespib; 1; 3; 4-oxadiazole; Isoxazole and anticancer; IN-VITRO; ANTIOXIDANT;
D O I：
10.1016/j.cdc.2022.100959
中图分类号：
O6 [化学];
学科分类号：
0703 ;
摘要：
A new library of diverse isoxazole contained 1,3-oxazole-1,3,4-oxadiazole heterocyclic hybrids have been synthesized (9a-j). The compounds were characterized by 1HNMR, 13CNMR & mass spectral data. Further, all derivatives were examined for their preliminary anticancer effects towards prostate cancer (PC3 and DU-145), lung cancer (A549) and breast cancer (MCF-7) human cancer cell lines by employing MTT method. The well-known clinical utilizing drug candidate as etoposide used as standard reference. All the tested compounds displayed moderate to good anticancer activity. Among them, four compounds 9a, 9b, 9c and 9 g possessed most promising activity than etoposide.
引用
收藏
页数：7
相关论文
共 50 条
  • [41] 1,3,4-oxadiazole and its derivatives: A review on recent progress in anticancer activities
    Vaidya, Ankur
    Pathak, Devender
    Shah, Kamal
    CHEMICAL BIOLOGY & DRUG DESIGN, 2021, 97 (03) : 572 - 591
  • [42] Design, Synthesis and Bioactivities of Novel Strobilurin Derivatives Containing 1,3,4-Oxadiazole Moity
    Liu, Yang
    Liu, Ming
    Chen, Minggui
    Wu, Changchun
    Hua, Xuewen
    Zhou, Sha
    Wang, Baolei
    Li, Zhengming
    CHINESE JOURNAL OF ORGANIC CHEMISTRY, 2017, 37 (02) : 403 - 410
  • [43] Design, synthesis, characterization, and biological evaluation of novel pyrazine-1,3,4-oxadiazole/[1,2,4] triazolo[3,4-b][1,3,4]thiadiazine hybrids as potent antimycobacterial agents
    Kumar, Shiva
    Dinesha, P.
    Udayakumar, D.
    Shetty, Varsha Prakash
    Deekshit, Vijaya Kumar
    JOURNAL OF MOLECULAR STRUCTURE, 2024, 1304
  • [44] Design, synthesis, chemical characterization, biological evaluation, and docking study of new 1,3,4-oxadiazole homonucleoside analogs
    El Mansouri, Az-Eddine
    Maatallah, Mohamed
    Benhassou, Hassan Ait
    Moumen, Abdeladim
    Mehdi, Ahmad
    Snoeck, Robert
    Andrei, Graciela
    Zahouily, Mohamed
    Lazrek, Hassan B.
    NUCLEOSIDES NUCLEOTIDES & NUCLEIC ACIDS, 2020, 39 (08) : 1088 - 1107
  • [45] Synthesis and biological evaluation of aryl 1,2,4-oxadiazole incorporated (2-(oxazol)-1H-imidazoles as anticancer agents
    Bairi, Suresh
    Alagarsamy, Veerachamy
    Rachamalla, Shyam Sunder
    Eppakayala, Laxminarayana
    RESULTS IN CHEMISTRY, 2022, 4
  • [46] Synthesis and biological evaluation of 1, 2, 3-triazole incorporated pyrrole derivatives as anticancer agents
    Nalla, Somaiah
    Aravind, S.
    Annam, Sri Charitha
    Padmavathi, K. V.
    Syed, Tasqeeruddin
    Subbarao, Mannam
    SYNTHETIC COMMUNICATIONS, 2024, 54 (21) : 1828 - 1841
  • [47] Synthesis of some novel 1,2,4-triazole and 1,3,4-oxadiazole derivatives of biological interest
    Patil, Bhimagouda S.
    Krishnamurthy, G.
    Lokesh, M. R.
    Shashikumar, N. D.
    Naik, H. S. Bhojya
    Latthe, Prashant R.
    Ghate, Manjunath
    MEDICINAL CHEMISTRY RESEARCH, 2013, 22 (07) : 3341 - 3349
  • [48] Synthesis and cytotoxic activity evaluation of some new 1, 3, 4-oxadiazole, 1, 3, 4-thiadiazole and 1, 2, 4- triazole derivatives attached to phthalimide
    Hassanzadeh, Farshid
    Jafari, Elham
    Shojaei, Faezeh
    Sadeghi-Aliabadi, Hojjat
    RESEARCH IN PHARMACEUTICAL SCIENCES, 2021, 16 (06) : 634 - 642
  • [49] Exploring 1,3,4-Oxadiazole Derivatives as Potent α-Amylase Inhibitors: and Evaluation
    Chavan, Shivani U.
    Waghmare, Sonali A.
    Bodke, Shraddha S.
    Bendale, Atul R.
    EURASIAN JOURNAL OF CHEMISTRY, 2023, 112 (04): : 30 - 43
  • [50] New antiproliferative 1,3,4-oxadiazole/benzimidazole derivatives: Design, synthesis, and biological evaluation as dual EGFR and BRAFV600E inhibitors
    Hagar, Fatma Fouad
    Abbas, Samar H.
    Sayed, Ahmed M.
    Gomaa, Hesham A. M.
    Youssif, Bahaa G. M.
    Abdelhamid, Dalia
    Abdel-Aziz, Mohamed
    BIOORGANIC CHEMISTRY, 2025, 157
12345